The TRIUMPH 4 trial reported the following rates at the 12mg dose level
Lee JS, Song WS, Lim JW, et al
Your personalized compounded GLP-1, prescribed by a licensed provider Free, discreet shipping straight to your door Unlimited care team access, message or video anytime Ongoing provider check-ins, with dose adjustments as you go No auto-billing
Confirmed for 2026 Medicare GLP-1 Bridge Program July 1, 2026 The Medicare GLP-1 Bridge program launches July 1, 2026 , covering Zepbound KwikPen for obesity for the first time
Many UK residents are searching for next-generation obesity treatments due to limited access to GLP-1 medications like Wegovy, ongoing NHS shortages, and strict patient eligibility criteria